Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. 1996

Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Japan.

Rat carrageenin-induced pleurisy was used to clarify the role of prostaglandin H synthase (PGHS)-2 in acute inflammation. Intrapleural injection of 0.2 ml of 2% lambda-carrageenin induced accumulation of exudate and infiltration of leukocytes into the pleural cavity. When PGHS-1 and -2 proteins in the pleural exudate cells were analyzed by Western blot analysis, PGHS-2 was detectable from 1 hr after carrageenin injection. Its level rose sharply, remained high from 3 to 7 hr after injection, and then fell to near the detection limit. PGHS-1 was also detected, but kept almost the same level throughout the course of the pleurisy. Levels of prostaglandin (PG) E2 and thromboxane (TX) B2 in the exudate increased from hour 3 to hour 7, and then declined. Thus, the changes of the level of PGE2 were closely paralleled those of PGHS-2. The selective PGHS-2 inhibitors NS-398, nimesulide and SC-58125 suppressed the inflammatory reaction and caused a marked decrease in the level of PGE2 but not in those of TXB2 and 6-keto-PGF 1 alpha. These results suggest that the PGHS-2 expressed in the pleural exudate cells may be involved in PGE2 formation at the site of inflammation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D009578 Nitrobenzenes BENZENE derivatives carrying nitro group substituents.
D010994 Pleura The thin serous membrane enveloping the lungs (LUNG) and lining the THORACIC CAVITY. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the PLEURAL CAVITY which contains a thin film of liquid. Parietal Pleura,Visceral Pleura,Pleura, Parietal,Pleura, Visceral
D011451 Prostaglandin-Endoperoxide Synthases Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor. Fatty Acid Cyclo-Oxygenase,PGH Synthase,Prostaglandin H Synthase,Prostaglandin Synthase,Prostaglandin-Endoperoxide Synthase,Arachidonic Acid Cyclooxygenase,Cyclo-Oxygenase,Cyclooxygenase,Cyclooxygenases,Hydroperoxide Cyclase,PGH2 Synthetase,Prostaglandin Cyclo-Oxygenase,Prostaglandin Cyclooxygenase,Prostaglandin Endoperoxide Synthetase,Prostaglandin G-H Synthase,Prostaglandin H2 Synthetase,Prostaglandin Synthetase,Cyclase, Hydroperoxide,Cyclo Oxygenase,Cyclo-Oxygenase, Fatty Acid,Cyclo-Oxygenase, Prostaglandin,Cyclooxygenase, Arachidonic Acid,Cyclooxygenase, Prostaglandin,Endoperoxide Synthetase, Prostaglandin,Fatty Acid Cyclo Oxygenase,G-H Synthase, Prostaglandin,Prostaglandin Cyclo Oxygenase,Prostaglandin Endoperoxide Synthases,Prostaglandin G H Synthase,Synthase, PGH,Synthase, Prostaglandin,Synthase, Prostaglandin G-H,Synthase, Prostaglandin H,Synthase, Prostaglandin-Endoperoxide,Synthases, Prostaglandin-Endoperoxide,Synthetase, PGH2,Synthetase, Prostaglandin,Synthetase, Prostaglandin Endoperoxide,Synthetase, Prostaglandin H2
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D002351 Carrageenan A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES. Carrageenin,iota-Carrageenan,kappa-Carrageenan,lambda-Carrageenan,iota Carrageenan,kappa Carrageenan,lambda Carrageenan
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell

Related Publications

Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
November 1994, British journal of pharmacology,
Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
December 2004, The Journal of pharmacology and experimental therapeutics,
Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
January 1980, Advances in prostaglandin and thromboxane research,
Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
November 2001, FEBS letters,
Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
September 1998, Biochemical pharmacology,
Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
December 1999, Naunyn-Schmiedeberg's archives of pharmacology,
Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
August 1979, Nihon Kyobu Shikkan Gakkai zasshi,
Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
August 2000, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
January 1997, Advances in experimental medicine and biology,
Y Harada, and K Hatanaka, and M Kawamura, and M Saito, and M Ogino, and M Majima, and T Ohno, and K Ogino, and K Yamamoto, and Y Taketani, and S Yamamoto, and M Katori
March 1999, European journal of pharmacology,
Copied contents to your clipboard!